Citation Impact
Citing Papers
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
Porcine Induced Pluripotent Stem Cells Produce Chimeric Offspring
2010
Therapeutic potential of complement modulation
2009
Antibody–gold quantum dot–PAMAM dendrimer complex as an immunoglobulin immunoassay
2008
Engineering precision nanoparticles for drug delivery
2020 Standout
Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn’s Disease
2006
C1 inhibitor: molecular and clinical aspects
2005
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation
2014 Nobel
Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease
1994
Induced Pluripotent Stem Cells: Past, Present, and Future
2012 StandoutNobel
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
2015
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018 StandoutNobel
Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom☆☆☆★★★
1998
Glycopeptide dendrimers. Part I
2007
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
1999 StandoutNobel
Guillain-Barré syndrome
2016 Standout
Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
1996
Inosculation of Tissue-Engineered Capillaries with the Host's Vasculature in a Reconstructed Skin Transplanted on Mice
2005
Synthesis of propyl and 2-aminoethyl glycosides of α-d-galactosyl-(1→3′)-β-lactoside
2001
Polyacrylamide-based glycoconjugates as tools in glycobiology
1998
Glycopeptide dendrimers. Part II
2007
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Functions of natural killer cells
2008 Standout
Induction and differential regulation of bee venom phospholipase A2–specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells
1997
A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes
2009
Membrane complement regulatory proteins
2005
Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera
2003
Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases
2008
Genomic Analysis of Reactive Astrogliosis
2012 Standout
Regulation of IgE and IgG responses by allergen specific T-cell clones to bee venom phospholipase A in vitro
1994
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity
2021
Self-Tolerance Checkpoints in B Lymphocyte Development
1995
Taking Complement to the Clinic – has the Time Finally Come?
2009
Capturing complex 3D tissue physiology in vitro
2006 Standout
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Elevated nucleosome levels in systemic inflammation and sepsis*
2003
Clonal selection and learning in the antibody system
1996 StandoutNature
Microenvironmental regulation of metastasis
2008 Standout
Role of interleukin 10 in specific immunotherapy.
1998 Standout
Synthesis and Microcontact Printing of Dual End‐Functionalized Mucin‐like Glycopolymers for Microarray Applications
2009 StandoutNobel
Harmful molecular mechanisms in sepsis
2008
Dendritic cell metabolism
2014
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Multifarious roles of sialic acids in immunity
2012
The acute respiratory distress syndrome
2012 Standout
B Cell Responses: Cell Interaction Dynamics and Decisions
2019
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Anti‐Carbohydrate Antibodies Elicited by Polyvalent Display on a Viral Scaffold
2007
Guillain-Barré syndrome
2005 Standout
Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review
2007
Extracellular histones are major mediators of death in sepsis
2009 Standout
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
2012 Standout
Blocking endothelial adhesion molecules: a potential therapeutic strategy to combat atherogenesis
2004
Naturally Arising CD4+Regulatory T Cells for Immunologic Self -Tolerance and Negative Control of Immune Responses
2003 StandoutNobel
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Immunometabolism governs dendritic cell and macrophage function
2015 Standout
Synthesis of Glycopolymers for Microarray Applications via Ligation of Reducing Sugars to a Poly(acryloyl hydrazide) Scaffold
2010 StandoutNobel
Dendritic polymers in glycobiology
2005
Designing Hydrogels for On-Demand Therapy
2017
Advances in Biomaterials for Drug Delivery
2018
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
2003
Impact of β2 integrin deficiency on mouse natural killer cell development and function
2011 StandoutNobel
Gold and nano-gold in medicine: overview, toxicology and perspectives
2009
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Cutting Edge: Priming of NK Cells by IL-18
2008 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
A Self-Assembled Multivalent Pseudopolyrotaxane for Binding Galectin-1
2004 StandoutNobel
Inflammation‐Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti‐PD1 Antibody
2016
Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47nullcells
2007
TLRs and innate immunity
2008 StandoutNobel
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Bioresponsive materials
2016
Characteristics of protein–carbohydrate interactions as a basis for developing novel carbohydrate‐based antirejection therapies
2005
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Guillain–Barré syndrome, CIDP and other chronic immune‐mediated neuropathies
1998
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
2018 Standout
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
2020 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy
2017 Standout
Works of Robert Rieben being referenced
P-selectin blocking potency of multimeric tyrosine sulfates in vitro and in vivo
2003
The Complement Inhibitor Low Molecular Weight Dextran Sulfate Prevents TLR4-Induced Phenotypic and Functional Maturation of Human Dendritic Cells
2008
Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood
2005
Antiganglioside GM1 Antibodies and Their Complement Activating Capacity in Central and Peripheral Nervous System Disorders and in Controls
1998
Isotype‐specific detection of ABO blood group antibodies using a novel flow cytometric method
2005
Xenograft rejection: IgG, complement and NK cells team up to activate and destroy the endothelium
2004
IN VITRO EVALUATION OF THE EFFICACY AND BIOCOMPATIBILITY OF NEW, SYNTHETIC ABO IMMUNOABSORBENTS
1995
Quantification of IgG and IgG4 antibodies to bee venom phospholipase A2 by competitive inhibition in ELISA
1989
Self tolerance to human A and B histo‐blood group antigens exists at the B cell level and cannot be broken by potent polyclonal B cell activation in vitro
1992
Design of the blood group AB glycotope
2005
Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy1
2002
Endothelial cell protection in xenotransplantation: looking after a key player in rejection
2006
Quantitation and characterization of anti‐Galα1–3Gal antibodies in sera of 200 healthy persons
1999
Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1
2007
Neoglycoconjugates Based on Dendrimer Poly(aminoamides)
2002
SUCCESSFUL MANAGEMENT OF A B-TYPE CARDIAC ALLOGRAFT INTO AN O-TYPE MAN WITH 31/2-YEAR CLINICAL FOLLOW-UP1
2001
Histo‐Blood Group Antigens as Allo‐ and Autoantigens
2005
C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction
2002
Synergy between Plasma Exchange and Intravenous Immunoglobulin
2015
CLEARANCE OF MOBILIZED PORCINE PERIPHERAL BLOOD PROGENITOR CELLS IS DELAYED BY DEPLETION OF THE PHAGOCYTIC RETICULOENDOTHELIAL SYSTEM IN BABOONS1
2001
Effects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1α and Dendritic Cell Maturation under Normoxic Conditions
2010
Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1->3Gal IgM and IgG antibodies
2000
Endothelial Cell Protection by Dextran Sulfate: A Novel Strategy to Prevent Acute Vascular Rejection in Xenotransplantation
2004
Detection, immunoabsorption, and inhibition of cytotoxic activity of anti‐αGal antibodies using newly developed substances with synthetic Gal α1–3Gal disaccharide epitopes
1995
A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft
2014
Synthesis of neoglycoconjugate dendrimers
1999
Intravenous immunoglobulins – understanding properties and mechanisms
2009